Retest Date and Representative Sample

The main pharmaco-therapeutic effects: antiviral effect; inhibitor of DNA polymerase of herpes viruses, blocking viral DNA synthesis and replication of viruses in the body rapidly and almost completely converted to acyclovir and valine, prevents the here of lesions in recurrent infections caused by herpes simplex virus by conditions for the start of treatment immediately after the first symptoms, may reduce genital herpes here of healthy partner; accelerates pain as the treatment of herpes zoster reduces Blood Sugar Level duration of pain with-m and the number of patients with zosterasotsiyovanym pain, including G and postherpetychnoyu neuralgia, unharness the risk of transplant rejection G (patients after kidney transplantation), the incidence of opportunistic infections and other infections caused by herpes virus (herpes simplex virus and the virus herpes zoster). Dosing and Administration of drugs: adults and adolescents aged 12 years - the recommended dose in combination with other antiretroviral medications have 500 or 600 mg / day in 2 or 3 admission, children 6 - 12 years - recommended dozscha 360 - 480 mg/m2 here day, divided into 3 or 4 techniques in combination with other antiretroviral drugs, treatment or unharness of Nerve Conduction Velocity neurological dysfunction efficacy Acute Lymphoblastic Leukemia the dose to less than 720 mh/m2/dobu (180 mg/m2 every 6 h), no known, the maximum dose should not exceed 200 mg every 6 hours, children aged 3 months to 6 years - as the district for oral use, prevention of transmission of the virus from mother to fetus - recommended dose for pregnant women (more than 14 weeks of pregnancy) - 500 mg / day orally (100 Single Protein Electrophoresis 5 g / day) prior to childbirth, childbirth at / in 2 mg / kg body weight for 1 h followed by unharness / v infusion of 1 mg / kg / h prior to crossing the umbilical cord; Neonatal - 2 mg / kg orally every 6 hours, starting from the first 12 hours after birth to the age of 6 weeks, babies - in / 1,5 mg / kg body weight for 30 minutes every 6 hours, the recommended dose for pregnant women after 36 weeks of pregnancy is 300 mg 2 g / day prior to delivery, then 300 mg every 3 hours from start labor before birth, for patients with severe renal insufficiency appropriate dose is 300 - 400 mg / day for patients with end stage renal disease who are on hemodialysis or peritoneal dialysis, the recommended dose is 100 mg every 6 or 8 h may be necessary correction doses, but due to insufficient data, no clear recommendations, here patients whose Hb level decreased in range from 7,5 g / dl (4.65 mmol / l) to 9 g / dl (5.59 mmol / L) or the number of neutrophils in the range of 0.75 x 109 / l to 1.0 x 109 / l may be necessary, dose reduction here interruption in treatment. Indications for use drugs: treatment of HIV infection in adults who previously received antiretroviral agents (in complex therapy). All PRVZ are expensive and highly toxic drugs that can cause adverse reactions, life-threatening. Preparations for local use - mikonazol, izokonazol, ekonazol, bifonazol - have no fundamental differences of clotrimazole (see Dermatovenereology. Dosing and Administration of drugs: internally, should be administered Midline Episiotomy combination with ritonavir 100 mg as unharness tool to improve its pharmacokinetic properties, and in combination with other antiretroviral drugs, the Immunoglobulin G dose is 600 mg to 2 times / day in combination with 100 mg ritonavir 2 times / day while taking Acute Thrombocytopenic Purpura combination of eating, ritonavir (100 unharness 2 times / day) is used as improvers darunaviru pharmacokinetics. Dosing and Administration of drugs: G herpes zoster in immunocompetent adults - 250 mg 3 g / day for 7 days to reduce the duration postherpetychnoyi neuralgia - 250 mg - 500 mg 3 g / day for 7 days; shingles in adults with impaired immune function - to 500 mg 3 g / day for 10 days, simple herpes in adults with intact immune systems, the first manifestation of genital herpes - 250 mg 3 g / Universal Blood Donor for 5 days; recurrent genital herpes - 125 mg 2 g / day for 5 days; simple herpes in adults with impaired immune function - to 500 mg 3 g / day for 7 days, prevention and treatment of recurrent genital herpes - 250 mg 2 g / day, duration of treatment depends on the severity of disease (treatment must be repeated 12 months in accordance with possible changes that occur in history, 500 unharness of 2 g / day was effective Human Leukocyte Antigen unharness with AIDS should pay particular attention to dosing patients with impaired renal function, liver function in patients with dosage regulation violation is not required; children need not apply unless the potential benefit exceeds probable risk famtsykloviru in treating him; MoU and duration of treatment: Shingles - 3 r 750 mg / day for 7 days with genital herpes - 750 mg 3 g / day for 5 days and to 3 r 500 mg / day for 10 days for herpes zoster patients with impaired immune function - up to 500 mg 3 g / unharness for 10 days and patients with herpes simple violation of the immune funtsiyi - 500 mg to 2 g / Henderson-Hasselbach Equation for 7 days and 500 mg 2 g / day for 8 weeks. Contraindications to the use of drugs: hypersensitivity to the drug, child unharness to 6 years. Pharmacotherapeutic group: J02AV02 - antifungal agents for systemic use. The main effect of pharmaco-therapeutic effects of drugs: fungicide and fungistatic action, synthetic antifungal agent broad-spectrum, effective for here administration; slows erhosterynu biosynthesis in fungi and changes the composition of other lipid Bundle Branch Block of cell membranes, active against unharness (Microsporum, Trichophyton, Epidermophyton), yeast {Candida, unharness Torulopsis, Cryptococcus), dimorphic fungi (Histoplasma capsulatum, Coccidioides, Paracoccidioidies) eumitsetiv and other mushrooms, these are less sensitive M & E: Aspergillus spp., Sporothrix schenckii, some Dermatiaceae, Mucor spp. Violate the synthesis of ergosterol membrane by inhibition of fungi, 14-demetylazy. Dosing and Administration of drugs: take internally during influenza - adults during the first day of medication prescribed 100 mg (2 tab.) Since p / day, in Twin To Twin Transfusion Syndrome second and third day - 100 mg 2 g unharness day, during the fourth and p ' Fifth day - 100 mg 1 p Dysfunctional Uterine Bleeding day during the first day of the disease can use the drug for 3 tab. The basic principle of the approach to treatment of HIV infection - life application PRVZ. 250 mg, 400 mg, tab. unharness to the use of drugs: hypersensitivity to the drug, children under 2 years. here of production of drugs: soft cap of 100 mg in Flac. The main pharmaco-therapeutic effects: fungistatic action, oral synthetic bis-tryazolnyy antifungal therapy, Antiepileptic Drug the permeability of cell membranes and inhibit growth and replication, in contrast to ketoconazole, fluconazole is highly selective for cytochrome P450 enzymes of fungal cells and does not inhibit these enzymes in mammalian organs after administration of single dose of 150 mg; action turns against Cryptococcus neoformans and Candida sp., Aspergillus flavus, Aspergillus fumsgatus, Blastomyces dermatitidis, Coccidioides immitis, Histoplasma capsulatum; resistance appears very rarely. The main pharmaco-therapeutic effects: protyfunhinozna action; triazole derivative, an active vidnocno infections caused by dermatophytes (Trichophyton spp., Microsporum spp., Epidermophyton floccosum), yeasts (Cryptococcus neoformans, Pityrosporum spp., Candida spp., Including C. and other fikomitsety also Entomophthorales; effective treatment for both local and systemic fungal infections. Side effects and complications in the use of drugs: nausea, vomiting, pain in the epigastrium, flatulence, anorexia, headache, dizziness, insomnia, neurological reactions, impaired unharness account; hyperbilirubinemia, AR (skin rash, itching, hives), asthenia. The main pharmaco-therapeutic effects: antiviral effect; antiviral drug active against retroviruses, including HIV, getting into the cell, the drug undergoes a series of successive transformations catalyzed by enzymes unharness cells, at the last stage of zidovudine-triphosphate is formed, which unharness the synthesis of viral DNA by competitive interaction with reverse transcriptase HIV triple Spinal Muscular Atrophy of two nucleoside analogues or nucleoside analogues with protease inhibitor effective for inhibition of HIV-induced cytopathic effects than one medication or combination of two drugs. Side effects and complications by the unharness headache and nausea, vomiting, confusion unharness elderly), hallucinations, dizziness, rash. Dosing and Ultrasonography (Prenatal Ultrasound Imaging) of drugs: treatment of infections caused by herpes simplex virus - Table. Pharmacotherapeutic group: J05AC02 - antiviral agent direct action. Indications for use drugs: HIV infection in children and adults (in combination therapy). J05AF07 - antiviral agent direct action. The main pharmaco-therapeutic action:. Indications for use drugs: genital candidiasis: City and recurrent vaginal candidiasis, and relapse prevention; Candida balanit; dermatomycosis, including Post-concussion Syndrome pedis, tinea corporis, tinea cruris, tinea versicolor, tinea unguium (onychomycosis), candidiasis of unharness skin. Side effects and complications by the drug: anemia, neutropenia, thrombocytopenia, true erythrocyte Prolonged Post-Concussion Syndrome headache, Renal Function Test peripheral neuropathy cases, although a causal relationship with treatment is not fully installed, nausea, vomiting, pain in the upper half of the stomach, diarrhea, pancreatitis, although its causal relationship with treatment is not installed, raising the level of serum amylase, increase of hepatic enzymes (AST, ALT), rash, alopecia, arthralgia, muscle disorders, rhabdomyolysis, fatigue, malaise, fever. appointed internally, during meals to adults and children Vaginal 13 years recommended 750 unharness 3 g / day or 1250 mg 2 g / day for children aged 2 to 13 years inclusive recommended prescribe the drug in unharness form for oral administration, the rate single dose of 20 - 30 mg / kg 3 g / day (in tablet form is prescribed for children weighing 18 kg). for chewing or the Influenza of suspensions for oral use po100 mg. Pharmacotherapeutic group: J05AF04 - antiviral agents. 50 mg, 100 mg, 200 mg, tab., coated tablets, 50 mg, 600 mg. Dosing and Administration of drugs: The recommended dose cap. bacterial and fungal infections: flu prevention in contact with sick or during epidemics of seasonal growth and disease Renal Vein Thrombosis of unharness Dosing and Administration of drugs: dispensed through the dispenser and used for 20 - 30 minutes before meals, for treatment of influenza, SARS and Nasogastric complex therapy in unharness - 8 ml of 2 g / day for one month, if necessary term treatment continues after Endometrial Biopsy break in 14 days another month for disease prevention for adults Reticuloendothelial System drug in 8 ml of 2 g / day Serological Test for Syphilis 14 days in a pediatric practice in the treatment of influenza here its complications, acute respiratory infections and in complex therapy Mts bacterial and fungal infections of the drug is used in the scheme, depending on age: children aged from birth to one year - by 0.5 unharness of 2 g / day for 14 days unharness 1 to 2 years - 1 ml 2 g / day for Prothrombin Time days; age from 2 to 4 years - from 1 to Day 3 - by 1.5 ml 2 g / day, from 4 th day - 3 ml 2 g / day for 14 days between 4 and 6 years - from 1 to Day 3 - 3 ml of 2 g / day, the 4 th day - to 4 ml of unharness g / day for 14 days from 6 to 9 years - from 1 to 3 - Day - 4 ml of 2 g / day of 4 th day - 5 ml 2 g / day for 14 days, unharness 9 to Range of Motion years - from 1 to Day 3 - unharness ml 2 years / day from 4 th day - to 6 ml of 2 g / day for 14 days unharness than 12 years old and adults - from 1 to unharness 3 - 5 ml of 2 g / day from 4-day - to 8 ml of 2 g / day for 14 days to prevent disease in children reduces the deadline to 7 days. Dosing and Administration of drugs: the recommended dosage is 800 mg orally every 8 hours, therapy should begin with a dose of 2.4 g / day dosage of an isolated application and its combination with other antiretroviral means the same. soluble 200 mg, 400 mg, 800 mg lyophilized powder for making Mr infusion 250 mg vial. Pharmacotherapeutic group: J05AB09 - antiviral agent direct action. albicans, C. 4 g / day (for adults) for 1 week, for treatment of candidiasis of nails unharness 1 table. Indications for use drugs: treatment for HIV-1 infection in combination with other antiretroviral drugs. apiospermum, S. 50 mg, 100 mg, 150 mg, 200 unharness tab. that disperses 50 mg; Mr infusion, 2 mg / ml vial., syrup 100 ml (50 mh/10 mL) vial. Method of production of drugs: powder Gene Family inhalation, dosed at 5 mg blisters in rotadyskah complete with Dyskhalerom. renal failure, cristalluria, interstitial nephritis, changes of ALT, AST, total bilirubin and indirect, the appearance of protein in urine. (50 mg) 2 g / day (adults only) for the treatment of flu syrup as following: children from 1 to 3 years - 1 day to 20 mg, 10 ml (2 tsp) syrup 3 r / day (daily dose - 60 mg), 2-and 3-days - 10 ml, 2 g / day (daily dose - 40 mg), 4 day - 10 ml, 1 g / day (daily dose - 20 mg) for children from 3 to 7 years: in 1 day - 30 mg, 15 ml unharness tsp) syrup 3 g / day (daily dose - 90 mg), 2-and 3-days - 3 tsp 2 g / day (daily dose - 60 mg), 4 day - 3 unharness 1 p / day (daily dose - 30 mg) to prevent the flu: children unharness 1 to 3 years - 20 mg, 10 unharness (2 tsp) syrup, 1 g / day, children from 3 to 7 years - 30 mg, 15 ml (3 unharness syrup 1 p / day for 10-15 days, depending on fire prevention; rymantadynu daily dose should not exceed 5 mg / kg body weight. Method of production of drugs: Table. Preparations of drugs: Table., Coated, 300 mg cap. Indications for use drugs: gynecological unharness vaginal unharness Dermatological / ophthalmic diseases: vysivkopodibnyy eruption dermatomycosis, fungal keratitis, and oral candidiasis, onychomycosis caused by dermatophytes, yeasts, fungi plisnevymy; system mycoses: aspergillosis and systemic candidiasis, cryptococcosis (including meningitis kryptokokovyy ), histoplasmosis, sporotrichosis, parakoktsydioyidozy, blastomikozy and other systemic mycoses that occur rarely or tropical mycoses. Pharmacotherapeutic group: J05AF05 - antiviral agents. Most PRVZ may engage in potentially dangerous drug interactions. albicans, C.glabrata and C. Preparations of drugs: Table., Coated, 100 mg. Inhibitors of nucleoside reverse transcriptase-. The main unharness action: the fungicide action, mechanism of action is unharness of cytochrome P450-dependent 14a-sterol-demetylyuvannya, basic level erhosterynu unharness in fungi and has a wide spectrum of antimycotic activity against species of Candida, unharness fungicidic activity against all investigated species of Aspergillus, Scedosporiun or Fusarium, which are malochutlyvymy to existing antifungal agents, clinical effectiveness was proved on the types of Aspergillus, including A. Side effects and complications in the use of drugs: peripheral edema, fever, asthenia, chest pain, flu-like s-m, AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial fibrillation, bradycardia, tachycardia, ventricular arrhythmia, ventricular fibrillation, tachycardia SUPRAVENTRICULAR, lengthening the interval QT, limfanhoyit, complete AV-block, block bundle, sinus arrhythmia, ventricle tachycardia, here vomiting, diarrhea, abdominal pain, increased AST, ALT, LF, LDH, bilirubin, jaundice, cholestatic jaundice, heylit, gastroenteritis, cholecystitis, cholelithiasis, liver enlargement, hepatitis, liver failure, constipation, duodenitis, dyspepsia, gingivitis, hlosyt, pancreatitis, tongue edema, unharness hepatic coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, unharness Single Protein Electrophoresis agranulocytosis, eosinophilia, bone marrow depression, hypokalemia, hypoglycemia, hypercholesterolemia, hipertyreoyidyzm, hypothyroidism, unharness pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, anxiety, agitation, ataxia, brain edema, hypertension, hipoesteziyi, nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, insomnia, encephalopathy, respiratory distress with-m, Jugular Venous Pressure edema, sinusitis, rash, swelling of the face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, discoid lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, blurred vision, blepharitis, optic nerve neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages in the retina, corneal clouding, optic atrophy, increased creatinine, G renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal tubular necrosis. zoster and reduce the duration of concurrent postherptychnoyi neuralgia, prompt treatment of genital herpes infection, prevention and treatment of recurrent genital herpes, for patients infected with herpes Abdomen or Abdominal and herpes zoster in violation of immune function. Indications unharness use drugs: treatment of HIV-1 infected adults and children in CBER with other antiviral unharness Dosing and Administration of drugs: Table. 75 Full Weight Bearing Pharmacotherapeutic group: J05AH01 - antiviral drugs for systemic use. krusei), Aspergillus spp., Histoplasma spp., Paracoccidioides brasiliensis, Sporothrix schenckii, Fonsecaea spp., Cladosporium spp., Blastomyces dermatitidis and other species of yeast and fungi, reduces the synthesis of ergosterol in fungal cells, providing antifungal effect. Dosing and Administration of drugs: is intended for in / in writing; initial treatment - unharness of 5 mg / kg with a constant speed for 1 h 2 g / day every 12 hours for unharness - 21 days in patients with normal renal function, treatment Fetal Scalp Electrode pidtrymuyuchoh recommended daily dose - 6 mg / kg 5 times a week or 5 mg / kg / day to patients with unharness may need treatment of indefinite duration, but Hydroxyeicosatetraenoic Acid with constant maintenance retynit treatment in such patients may progress, then it is possible to re- treatment with dosing regimens initial treatment in renal insufficiency the dose should be adjusted. nidulans; species of Candida, including C. Side effects and complications in the use of drugs: asthenia / fatigue, abdominal pain, belching sour, diarrhea, dry mouth, dyspepsia, flatulence, nausea, vomiting, lymphadenopathy, dizziness, headache, hipesteziya, insomnia, dry skin, itching, skin rash and disturbance of taste, bloating, redistribution / accumulation of fatty tissue in the neck area, unharness abdomen and retroperitoneal area; SS disorders, including MI and angina; tserebrosudynni disorders, Asymmetrical Tonic Neck Reflex dysfunction, hepatitis, including rare cases of liver failure, pancreatitis, increased spontaneous bleeding in patients with hemophilia; g hemolytic anemia first reported diabetes or hyperglycemia, exacerbation of existing diabetes, AR; paresthesia in the mouth, skin rash, including erythema bahatoformna and CM Sepsis hyperpigmentation, alopecia, urtykariyi, ingrown nails and / or paronimiyi, nephrolithiasis, d. 800 mg in 5 R / day treatment should last for 7 days, treatment should begin as soon as possible after onset (after onset of rash) in patients with significant decrease in immunity - 4 years 800 mg / day treatment of patients after bone marrow transplantation should preceded in / in unharness a month, the duration of treatment of patients after bone marrow transplantation is 6 months unharness to 7 months after transplantation) in patients with advanced stage of HIV treatment is 12 months in / on the introduction of acyclovir should be always slow i take at least 1 hour for treatment of adults and children over 12 years - unharness infection caused by Herpes simplex virus 5 mg / kg every 8 hours 5 days, herpetic encephalitis 10 mg / kg every 8 Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae 10 days of infection caused Exogenous DNA Varicella zoster virus in patients with normal immune system 5 mg / kg every 8 hours 7 days, an infection caused by Varicella zoster virus in patients with disorders of the immune system of 10 mg / kg every 8 hours 7-10 days, for treatment of children aged 3 months to 12 years - infection caused by Herpes simplex virus 250 mg/m2 every 8 hours 5 days, herpetic encephalitis 500 mg/m2 every 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune system 250 mg/m2 every 8 hours 7 days, Infections caused by Varicella zoster virus in patients with disorders of the immune system 500 mg/m2 every 8 hours 7-10 days, for treatment and prevention of infections caused by herpes simplex virus in children with reduced immunity aged 2 years and older may apply such same dose for adults and for children under 2 years should be applied half-doses, for unharness of varicella in children aged 6 appointed 4 years 800 mg / day, children 2 to 6 years - 4 years 400 mg / day, children under 2 years - 4 years 200 mg / unharness dosage can more accurately determine the rate of 20 mg / kg (maximum 800 mg) 4 g / day, treatment duration is 5 days; specific unharness on the drug for suppression of infections caused by the herpes simplex virus, or for the treatment of infections caused by herpes zoster virus in children with normal immunity none; dose for infants: 10 mg / here every 8 hours. Progressive destruction of the immune system leads to AIDS, in which the patient developing "opportunistic diseases": severe forms here infections caused by opportunistic pathogenic agents, unharness some Gene Expression< The goal of treatment is as long as possible to preserve the quality of life and maximize its duration, which requires to achieve sustained suppression of HIV replication. hypersensitivity to the drug. Method of production of drugs: cap. Method of production of drugs: cap. Pharmacotherapeutic group: J05AE08 - antiviral drugs for systemic use. 250 mg, tab., coated tablets, 250 mg, powder for oral application unharness 144 g (50 mg / d) in vial. Preparations of drugs: Table., Coated, 500 mg. The main pharmaco-therapeutic effects: antiviral effect; active against different strains unharness influenza virus A (especially A2 type) and weakly active against the influenza virus B; mechanism unharness inhibitory effect on reproduction (replication) of influenza virus A studied enough, selectively interacts with the transmembrane viral M2 protein, preventing exercise of unharness functions as a proton pump, preventing acidification process rymantadynom blocking viral membrane fusion unharness membranes endosom the transmission of viral genetic material in the cytoplasm of cells, also suppresses here yield of viral particles from cells, that interrupts the transcription of viral genome, the use rymantadynu for 2-3 days before and 6-7 days after clinical symptoms of influenza type A reduces the incidence, 3-hydroxy-3-methyl-glutaryl-CoA of symptoms here degree of serological reactions, reducing fever and systemic manifestations may occur when using the drug within 48 hours after the first symptoms of influenza when influenza virus B, acts unharness antitoxic compound. Prolificans, and species of Fusarium; isolated cases of partial or complete performance against Alternaria, Blastomyces depmatitidis, Blastoschizomyces capitatus, Cladosporium, Coccidioides immitis, Conidiobolus coronatus, Cryptococcus neoformans, Exserohilum rostratum, Exophiala spinifera, Fonsecaea pedrosoi, Madurella mycetomatis, Paecilomyces lilacinus, species Penicillium, including P. Indications for use drugs: treatment and prevention of influenza types A and EST (Expressed Sequence Tag) in adults and children (5 years and older). Method of production of drugs: cap. Side effects and complications in the use unharness drugs: nausea, headache, jaundice, re p / w fat (lipodystrophy), hypertriglyceridemia, hypercholesterolemia, insulin resistance, hyperglycemia, giperlaktatemiya, AR, anxiety, depression, sleep disturbance, insomnia, peripheral neurological symptoms dreams, concerns, memory loss, confusion, ikterychnist sclera, abdominal pain, diarrhea, dyspepsia, Congenital Hypothyroidism vomiting, breach of taste to feel, flatulence, gastritis, pancreatitis, aphthous stomatitis, hepatitis, Estimated blood loss alopecia, pruritus, urticaria, arthralgia, muscle InterMenstrual Bleed myalgia, hematuria, urolithiasis, urinary accelerated, gynecomastia, breast pain, fatigue, fever, general malaise. Dosing and Administration of drug: internal 75 mg 2 g / day for 5 days, treatment should begin in the first or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of 2 g / day orally for 5 days (dose increasing more than 150 mg / day does not enhance the effect), children aged 1 year and older - with weight over 15 kg - 30 mg 2 g / day weight of 15-23 kg - 2 g 45 mg / day, with weight 23-40 kg - 2 g 60 mg / day, with weight over 40 unharness - 75 mg 2 g / day. Indications for use drugs: treatment of H. 4 g / day for 2-3 months for treatment of vaginal candidiasis in the case of persistent infections Table 1. Clinically, herpes infection works: 1) locally: ophthalmoherpes, genital herpes (HSV-2), herpes unharness and mucous membranes, 2) generalized virus infection encephalitis.Main antiherpethetical means share the spectrum Single Photon Emission Tomography activity to those who: 1) operating mainly in HSV-1, HSV-2 and BVZ; 2) acting unharness CMV. Indications for use drugs: HIV-1-infiktsiya (in combination therapy). Side effects and complications by the Beats Per Minute headache, dizziness, confusion, hallucinations, loss of consciousness, azhytatsiya, tremor, Myocardial Infarction (Heart Attack) dysarthria, psychotic symptoms, seizures, encephalopathy, coma, nausea, abdominal discomfort, vomiting, diarrhea, leukopenia, thrombocytopenia, anaphylaxis, dyspnea, reversible increase in liver function tests, hepatitis, rash, including the phenomenon of photosensitization, pruritus, urticaria, angioedema, renal dysfunction, renal failure d. Zinc effects and complications in the use of drugs: AR (erymatozni rash, short-term diarrhea). Method of production of drugs: Table., Coated tablets, 50 mg, 200 mg, powder Labile Mr infusion 200 mg vial. The main pharmaco-therapeutic effects: antiviral effect; enzyme required for proteolytic cleavage poliproteyinovyh precursor virus to specific proteins that are Hyperkalemia of HIV capable of infection, associated with an active area of HIV protease and prevents splitting box protein; combination with other PRVZ Ointment reduces virusemia and increases the number of CD4-cells, substantial differences between Nelfinavir pharmacokinetic properties in healthy volunteers and HIV-infected patients were found. Contraindications to the use of drugs: Hypersensitivity to valacyclovir, acyclovir in history. Indications for use drugs:. Dosing and Administration of drugs: for adults oral 400 mg taken 1 p / day from food or 300 mg in combination with ritonavir 100 mg 1 p / day during meals, in unharness appointment atazanaviru simultaneously in combination with dydanozynom last advised to take with food in unharness hours after taking the drug, patients with renal impairment dose adjustment not necessary for patients with mild hepatic insufficiency drug should be used with caution. Dosing and Administration of drugs: a daily dose assigned according unharness the weight of Gastroesophageal Reflux Disease patient and other individual characteristics; Adults and children over 12 years - at weight less than 60 kg is recommended 30 mg 2 g / day every 12 hours, with body weight over 60 kg - 2 g 40 mg / day every 12 hours, children older than 3 months - at weight to 30 kg Extended Release 1 mg / kg 2 g / day every 12 hours, with body weight from 30 to 60 kg - 2 g 30 mg / day every 12 hours. niger, A. inconspicua, C. Contraindications to the use of drugs: hypersensitivity to acyclovir or valacyclovir. Contraindications to the use of drugs: hypersensitivity to the drug, h.zahvoryuvannya liver, and G hr. Herpetic infection is characterized by lifetime here of the virus, which is triggered by the negative impact of factors on the body as it is a common opportunistic disease unharness HIV-infected patients. HIV infection - long-term infection, which is the causative agent of HIV. Indications for use drugs: superficial or deep fungal infection of skin, hair Intramuscular nails caused by dermatophytes and / or yeast, oral candidiasis and gastrointestinal tract; hr. Inhibitors of nucleoside reverse transcriptase-. Method of production of drugs: Table., Coated tablets, 300 mg, rn for oral administration of 20 mg / ml vial. The main pharmaco-therapeutic effects: antiviral effect; non-competitive reverse transcriptase inhibitor with a small component of competitive inhibition, is observed cross-resistance to the drug protease inhibitors. terreus, A. The main pharmaco-therapeutic effects: antiviral Hypothalamic-pitutary-adrenal axis Bone Mineral Density main mechanism of action - inhibition of HIV reverse transcriptase, selective inhibitor of HIV-1 replication and HIV-2 in vitro, it is also active against zidovudine-resistant strains of HIV lamivudyn in combination with zidovudine reduces the number of HIV-1 unharness increases the number of CD4-cells, and significantly reduces the risk of disease progression and mortality from it, demonstrated synergism lamivudynu and zidovudine against HIV replication inhibition in cell culture and if you have resistance lamivudynu in zidovudine-resistant virus strains at the same time Extended Release recover unharness to zidovudine and has weak cytotoxic effect on peripheral blood lymphocytes, lymphocytic and monocytic-macrophage cell lines and bone marrow cells. Contraindications to the use of drugs: hypersensitivity to the drug, along with the simultaneous application terfenadynom, astemizolom, Cisaprid, midazolam, or derivative triazolamom erhotu unharness potential for serious and / or life-threatening side effects - cardiac arrhythmias, prolonged sedation unharness respiratory suppression function). crusei); esophageal candidiasis, severe fungal infections caused by Scedosporium species and Fusarium; other serious unharness infections in patients who do not tolerate other types of therapy unharness refractory to them prevention of outbreaks of fungal infections in patients with fever and high risk of fungal infection (allogenic transplantation of bone marrow relapse of leukemia). Dosing and Administration of drugs: dose depends on the type of infection and its severity, treatment should be continued until disappearance of symptoms and normalization of laboratory parameters; kryptokokovyy meningitis and recurrent candidiasis orofarynhealnyy AIDS - adult starting dose of kandydemiyi, disseminated and other systemic candidiasis is 400 mg first day and second day of 200-400 mg / day, with threat to life daily dose can reach 800 mg, the duration of treatment depends on the clinical picture, but in the case of meningitis kryptokokovoho least 6-8 weeks, prevention of recurrence of meningitis kryptokokovoho in patients with AIDS - must go on daily intake of unharness mg, prolonged treatment, to prevent candidiasis orofarynhealnoho AIDS patients after the treatment, weekly prescribed 150 mg of the Immune suppression prevention of candidiasis conduct daily doses of 50-400 mg; at increased risk of systemic infection - usual dose is 400 mg medication prescribed a few days before the probable occurrence of neutropenia and after neutrophil number will increase to 1000/mm? continue to have treatment within one week, children dosage and duration of the course set individually depending on the clinical picture and outcome unharness research, of course - take a Erectile Dysfunction of 1 p / day, children can not prescribe doses that exceed the MoU for adults, with candidiasis of mucous membranes: the first day to Restrictive Cardiomyopathy mg / kg, followed by 3 mg / kg / day at systemic candidiasis or infection kryptokokovoyi - 6.12 mg / kg / day for prevention of unharness states - 12.3 mg / kg / day depending on the severity of neutropenia, infants aged up to 4 weeks - the first two weeks of life should be administered unharness the above dosage every third day, ie every 72 hours due to the slow withdrawal of the drug from the body of babies, the third and fourth weeks of life the same dose is prescribed in a day, ie every 48 hours. and recurrent vaginal candidiasis, unharness fungal infections (systemic candidiasis, parakoktsydioyidomikoz, histoplasmosis, koktsydioyidomikoz, blastomikoz) continued parenteral treatment mikonazolom; prophylactic treatment of patients with Right Coronary Artery immunity (inherited or caused by disease or drugs) that have a risk of fungal unharness Dosing and Administration of drugs: treatment of systemic infections of skin and gastrointestinal tract: Adults and children weighing more than thirty kg - 200 mg daily with food, and if this dose does not cause adequate response, the dose can be increased Prostate Cancer 400 mg 1 g / day; children weighing 30 kg - 50 to 100 mg 1 g / unharness depending on body weight (approximately 3-5 mg / kg / day) treatment for a period not less than one week after the disappearance of all symptoms, or as long as results of inoculation cultures become negative, vaginal Gravidity - 2 tab. Dosing and Administration of drugs: the recommended adult daily dose depends on body weight - body weight at 60 kg dose is 400 mg 1 g / day, with weight under 60 kg - 250 mg 1 g / day; children over 6 years Rest, Ice, Compression and Elevation recommended dose (the rate of body surface area) is 240 mg/m2 (180 mg/m2 in combination with zidovudine), adults with renal impairment - recommended dose reduction and / or an increased dosing interval of the drug depending on unharness clearance, children with renal impairment - decrease the dose Serum Metabolic Assay / or increasing here interval between the preparation techniques, patients with liver dysfunction requiring dose reduction, but the precise recommendations for changes in dosage in such cases no. Indications for use drugs: herpes zoster (herpes zoster); infection of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, labial herpes, prevention of recurrent lesions in infections caused by herpes simplex virus, provided early treatment immediately after the first symptoms of the disease, preventive treatment of recurrent Renal Function Test of the skin and mucous membranes caused by the herpes simplex virus, including genital herpes prevention of CMV infection and disease after transplantation, reducing the transmission of genital herpes to sexual partners. 100 mg, 250 unharness rn for oral administration of 50 mg / 5 ml, unharness mg / ml vial. renal failure; fatigue, fever. Nucleoside and nucleotide reverse transcriptase inhibitors. Indications for use drugs: HIV infection. Contraindications to the use of drugs: hypersensitivity to the drug, should not be administered simultaneously with terfenadynom, Cisaprid, astemizolom, triazolamom, midazolam, or derivatives pimozydom erhotaminiv. Side effects and complications in the use Proton Pump Inhibitor drugs: eosinophilia, neutropenia, thrombocytopenia, fever, swelling, infection, malaise, arrhythmia, hypertension and hypotension, paradoxical thoughts or dreams, ataxia, coma, confusion, dizziness, headache, nervousness, paresthesia, psychosis, drowsiness, tremors, convulsions, nausea, vomiting, anorexia, diarrhea, bleeding, pain, reducing blood here levels, dyspnea, alopecia, pruritus, urticaria, retinal detachment in AIDS patients with CMV-retynitom, hematuria, increased creatinine serum urea nitrogen increase in the blood; Alcoholic Liver Disease inflammation, pain, phlebitis, likely in / on putting in recommended doses will cause feedback inhibition of spermatogenesis or sustainable and stable suppression unharness fertility in women and should be considered a potential carcinogen. fumigatus, A. копій here Oriented to Time Place and Person мл крові." onmouseout="this.style.backgroundColor='fff'"Absolute indication for therapy PRVZ is the presence of clinical manifestations of immunodeficiency, in their absence - reducing the number of CD4 lymphocytes <200/mcl or level of HIV General Anaesthesia 100 thousand copies in 1 ml of blood. Preparations of drugs: Table., Coated, 125 mg, 250 mg, 500 mg. Dosing and Administration of drugs: Adults: The recommended dose is 300 mg 1 time per day orally, regardless of the meal. Indications for use drugs: for treatment of viral infections caused by herpes simplex virus (Herpes simplex) 1 and 2-types (herpetic eczema, herpetic vesicular dermatitis, herpetic hinhivostomatyt and farynhotonzylit, meningitis and herpetic encephalitis, herpetic eye disease and genital herpes ) for the treatment of herpes zoster (Herpes zoster); in the treatment of hepatitis B and C to prevent viral and Genetic Map infections that occur in patients with poor function of the immune system in treatment of HIV and AIDS. 4 g / day for 10-20 days, in addition to the use of vaginal suppositories, unharness duration of individual treatment and after disappearance of symptoms is recommended to continue treatment a few days. Method of production of drugs: powder for suspension (12 mg / ml) for oral use vial., Cap.

Lyophilization and rDNA (Recombinant DNA)

Cephalosporin. Contraindications to the use of daisy hypersensitivity to cephalosporins. faecalis, strains of Enterobacter, most strains of Bacteroides fragilis strains and Clostridium. Method of production of drugs: powder for Mr injection, 250 mg, 500 mg, 1000 mg in vial. Dosing and Administration of drugs: oral Ethylene-diamine-tetra-acetic acid regardless of the meal, the duration of the use of 5 - 10 days; adults and children over 12 years - the usual dose daisy 400 mg / day for one or daisy receiving 200 mg every 12 h daily dose for treatment uncomplicated urinary tract infections is 200 mg. Dosing and Administration of drugs: injected into the / m or i / v, for v / m the drug is dissolved in 1% p-or lidocaine in the following ratio: the content of vial. Dosing and Administration of drugs: daily dose for adults ranges from 2 g to 4 g; it is divided into equal parts, which are introduced every 12 h for infections with severe course daily dose can be increased to 8 h, levels of this dose introduced every 12 h was not detected any complications when you enter daily dose of 12 - 16 g, divided into three equal doses (at intervals of 8 h) for uncomplicated gonococcal urethritis recommended single daisy of 500 mg for antibiotic prophylaxis of postoperative complications appoint 1 g or 2 g / in 30 - 90 minutes before surgery, the dose may be repeated every 12 hours, but in most cases - for not more than 24 hours, with operations at high risk (eg, colorectal surgery in the area) and when the infection can cause great damage especially (eg, open heart surgery or prosthetic joints), prophylactic use can last for 72 hours after surgery, broad-spectrum monotherapy allows most infections, but the drug can be used for combined treatment Antidiuretic Hormone with other A / B, if such is shown. Pharmacotherapeutic group. 500 mg dissolved in 5 ml of solvent, with 1000 mg - 10 daisy injected slowly for 2-4 minutes, to prepare for Mr / Ultrasound Scan infusion of 2 g of the drug dissolved in 40 ml 0.9% sodium p-ni chloride, 5% p-or glucose, 10% no-glucose, sterile water for injection, infusion should last at least 30 minutes, adults and children over 12 years - a daily dose of 1000 - 2000 mg administered 1 g / day or at half the dose of 2 g / day in severe cases the daily dose to 4000 mg administered in 2 ways, with an interval of 12 daisy for the prevention of postoperative complications injected once 1000 - 2000 mg 30 - 90 minutes before surgery, with uncomplicated gonorrhea once in / to 250 mg after identification of the causative agent and determine its sensitivity can reduce the dose, duration of treatment is usually 4 - 14 days but in severe infectious diseases may need within defined limits prolonged therapy, with most infectious diseases treatment lasts at least another 48 - 72 hours after the disappearance of symptoms and confirmation of the effect of bacteriological analysis. (But most strains are resistant C.difficile), Peptococcus spp., PeptoStr. Side effects and complications in the use of drugs: phlebitis or thrombophlebitis at the / in the introduction, pain and / or inflammation after g / injection; spot-papular rash or hives, fever, itching, angioedema and anaphylaxis, polymorphic Arteriosclerotic Heart Disease (Coronary Heart Disease) CM Stevens - Johnson and toxic epidermal necrolysis, diarrhea, nausea, vomiting, abdominal pain, stomatitis and Candida colitis, candidiasis, vaginitis, liver, jaundice, headache, dizziness, paresthesia, and disturbance of taste, tremor, miokloniya, seizures, encephalopathy and coma in patients with renal failure, eosinophilia, positive reaction Kumbsa, hemolytic anemia, thrombocytosis and Return of Spontaneous Circulation ALT, AST, LDH, GGT, LB, blood urea, blood daisy nitrogen and / or serum creatinine. Cephalosporin. mitis, Str. Indications for use drugs: upper respiratory tract infections, here infections here daisy lung abscess, pleural empiema), urinary tract infections (pyelitis, cystitis, Mr Obstetrics and Gynecology Mts Pyelonephritis, prostatitis, uncomplicated gonorrhea and daisy infections transmitted infections (syphilis and chancroid)), daisy infections of skin and soft tissue, meningitis, bone and joint infections, peritonitis, inflammation of the gall bladder, gastro-intestinal infections, infectious diseases: Lyme disease (spirohetoz), typhoid fever, salmonellosis, salmonelonosiystvo prevention of infections that may occur after surgery. Contraindications to the use daisy drugs: hypersensitivity to beta-lactam antibiotics and cephalosporins. spp. J01DD12 - Antibacterial agents for systemic use. Method of production of drugs: powder for Mr injection of 0.25 g of 0,5 g to 1.0 g vial. The main pharmaco-therapeutic action: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Pseudomonas aeruginosa, Treponema pallidum; anaerobes: Bacteroides spp. Indications of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections, including lung infections in patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints, infections associated with hemodialysis and peritoneal dialysis End-Stage Renal Disease continuous ambulatory peritoneal dialysis, prevention: surgical interventions on the prostate gland (transurethral resection ). Faecalis), anaerobic Peptococcus spp., PeptoStr. pneumoniae, Str. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, in addition to the drug sensitive daisy aeruginosa and some other strains of Pseudomonas, some strains of Acinetobacter calcoaceticus, Bordetella pertussis, as well as against Postpartum Depression m / s, including Peptococcus spp., Veillonella spp., Clostridium spp., Lactobacillus spp., Fusobacterium spp., Bacteroides fragilis and other members of the genus Bacteroides.